Yeluri Formulations Profile
Key Indicators
- Authorised Capital ₹ 3.15 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.33 Cr
as on 16-11-2024
- Company Age 28 Year,
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 48.22 Cr
as on 16-11-2024
- Satisfied Charges ₹ 40.78 Cr
as on 16-11-2024
- Revenue 6.25%
(FY 2023)
- Profit 13.61%
(FY 2023)
- Ebitda 69.00%
(FY 2023)
- Net Worth 3.87%
(FY 2023)
- Total Assets 22.71%
(FY 2023)
About Yeluri Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.15 Cr and a paid-up capital of Rs 2.33 Cr.
The company currently has active open charges totaling ₹48.22 Cr. The company has closed loans amounting to ₹40.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
Yeluri Prasad, Manogna Yeluri, Eluri Sridevi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230TG1997PTC026188
- Company No.
026188
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jan 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Yeluri Formulations Private Limited offer?
Yeluri Formulations Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Antibiotic Tablets, Capsule & Syrup, Cardiovascular Drugs & Medication, Anticoagulant and Antiplatelet Drugs, Nutraceuticals & Dietary Supplements, Vitamin & Multivitamin Injections, Antibiotic Injection, Digestive System Drugs & Medicines, Antacid Drugs.
Who are the key members and board of directors at Yeluri Formulations?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yeluri Prasad  | Managing Director | 01-Apr-2009 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manogna Yeluri | Additional Director | 28-Jun-2021 | Current |
| Eluri Sridevi | Director | 01-Apr-2009 | Current |
| Eluri Rao | Director | 01-Apr-2009 | Current |
Financial Performance of Yeluri Formulations.
Yeluri Formulations Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.25% increase. The company also saw a substantial improvement in profitability, with a 13.61% increase in profit. The company's net worth moved up by a moderate rise of 3.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yeluri Formulations?
In 2023, Yeluri Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sherrington Pharmaceuticals Private LimitedActive 22 years 3 monthsYeluri Prasad and Manogna Yeluri are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Oct 2024 | ₹4.00 Cr | Open |
Hdfc Bank Limited Creation Date: 18 Apr 2023 | ₹2.21 M | Open |
Hdfc Bank Limited Creation Date: 25 Feb 2020 | ₹44.00 Cr | Open |
How Many Employees Work at Yeluri Formulations?
Yeluri Formulations has a workforce of 86 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yeluri Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yeluri Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
